Shopping Cart
- Remove All
Your shopping cart is currently empty
Oleclumab (MEDI9447) is a human anti-CD73 monoclonal antibody with anticancer activity that inhibits the extracellular enzyme CD73 nucleic acid exonuclease activity, inhibits the adenosine pathway, and can be used for the study of metastatic desmoplasia-resistant prostate cancer.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $479 | In Stock | |
| 5 mg | $1,180 | In Stock | |
| 10 mg | $1,620 | In Stock | |
| 25 mg | $2,380 | In Stock |
| Description | Oleclumab (MEDI9447) is a human anti-CD73 monoclonal antibody with anticancer activity that inhibits the extracellular enzyme CD73 nucleic acid exonuclease activity, inhibits the adenosine pathway, and can be used for the study of metastatic desmoplasia-resistant prostate cancer. |
| In vivo | In the Murine Balb/c syngeneic CT26 colon carcinoma tumor model, intraperitoneal administration of Oleclumab (10 mg/kg; twice per week for 2 weeks) resulted in a significant inhibition of tumor growth by at least 50% from day 7 to day 16 compared to the isotype control antibody-treated groups[2]. |
| Synonyms | MEDI-9447, MEDI9447, MED I9447 |
| Molecular Weight | 143.14 kDa |
| Cas No. | 1803176-05-7 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.